Trials / Completed
CompletedNCT04912622
RPE Characterisation With Transscleral Optical Phase Imaging in Retinal Disorders
Cross Sectional Study: in Vivo Morphometric Characterisation of Human Retinal Pigment Epithelium With Transscleral Optical Phase Imaging in Photoreceptor/ Retinal Pigment Epithelium/ Bruch's Membrane/ Choriocapillaris Complex Disorders
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 210 (actual)
- Sponsor
- Luzerner Kantonsspital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Accumulating evidence suggest that the functional unit of photoreceptor/ retinal pigment epithelium (RPE)/Bruch's membrane/choriocapillaris plays a key role in pathophysiologic processes of a wide range of medical retinal disorders of the eye. Little is known about in vivo morphometric characteristics of human RPE cells as in vivo observation of these cells was so far technically challenging and hence nearly impossible to implement in a clinical setting. Transscleral optical phase imaging is a novel in-vivo microscopy technique allowing human RPE imaging on a cellular level with the potential of clinical application in a multimodal retinal imaging approach for diagnostic purpose in medical retina patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Clinical Trial | Retinal image acquisition with Cellularis version 2.0 |
Timeline
- Start date
- 2021-05-19
- Primary completion
- 2022-10-31
- Completion
- 2022-10-31
- First posted
- 2021-06-03
- Last updated
- 2023-03-07
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04912622. Inclusion in this directory is not an endorsement.